Literature DB >> 30913383

Discovery of δ Opioid Receptor Full Inverse Agonists and Their Effects on Restraint Stress-Induced Cognitive Impairment in Mice.

Shigeto Hirayama1,2, Takashi Iwai2,3, Eika Higashi1, Minami Nakamura3, Chiharu Iwamatsu1, Kennosuke Itoh1,2, Toru Nemoto1, Mitsuo Tanabe2,3, Hideaki Fujii1,2.   

Abstract

The cyclopropylmethyl group in classical δ opioid receptor (DOR) antagonist NTI, BNTX, and NTB was replaced with various electron-withdrawing groups to develop DOR inverse agonists. N-Benzyl NTB derivative SYK-657 was a potent DOR full inverse agonist and its potency was over 10-fold potent than that of a reference compound ICI-174,864. Intraperitoneal administration of SYK-657 induced the short-term memory improving effect in mice without abnormal behaviors.

Entities:  

Keywords:  DOR; cognitive impairment; constitutive activity; inverse agonist; δ opioid receptor

Mesh:

Substances:

Year:  2019        PMID: 30913383     DOI: 10.1021/acschemneuro.9b00067

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  3 in total

1.  Effects of N-Substituents on the Functional Activities of Naltrindole Derivatives for the δ Opioid Receptor: Synthesis and Evaluation of Sulfonamide Derivatives.

Authors:  Chiharu Iwamatsu; Daichi Hayakawa; Tomomi Kono; Ayaka Honjo; Saki Ishizaki; Shigeto Hirayama; Hiroaki Gouda; Hideaki Fujii
Journal:  Molecules       Date:  2020-08-20       Impact factor: 4.411

2.  Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists.

Authors:  Parthasaradhireddy Tanguturi; Vibha Pathak; Sixue Zhang; Omar Moukha-Chafiq; Corinne E Augelli-Szafran; John M Streicher
Journal:  Molecules       Date:  2021-11-05       Impact factor: 4.927

3.  Synthesis of Fluorinated Amide Derivatives via a Radical N-Perfluoroalkylation-Defluorination Pathway.

Authors:  Zhiyao Zheng; Angela van der Werf; Marie Deliaval; Nicklas Selander
Journal:  Org Lett       Date:  2020-03-25       Impact factor: 6.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.